Hrt Financial LP Axsome Therapeutics, Inc. Transaction History

Hrt Financial LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	SELL	$57.42 - $83.61 $209,812 - $305,510	-3,654 Reduced 28.25%	9,279 $738,000
Q3 2023 Nov 13, 2023	BUY	$69.25 - $82.21 $895,610 - $1.06 Million	12,933 New	12,933 $903,000
Q1 2020 May 15, 2020	SELL	$41.2 - $101.31 $1.67 Million - $4.1 Million	-40,503 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$16.71 - $106.24 $676,805 - $4.3 Million	40,503 New	40,503 $4.19 Million

326

37.7M

912K

855K

Ticker AXSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,878,000
Market Cap $3.99B
Description
Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

Stay updated on Hrt Financial LP with notifications on news.